Hyperfine (HYPR) Cost of Revenue (2021 - 2026)
Hyperfine's (HYPR) quarterly Cost of Revenue came in at $1.9 million in Q1 2026, up 53.43% YoY from $1.3 million in Q1 2025, and down 25.97% on a QoQ basis from $2.6 million in Q4 2025.
Hyperfine (HYPR) Cost of Revenue (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Cost of Revenue data on file, last reported at $1.9 million in Q1 2026.
- Quarterly Cost of Revenue rose 53.43% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 18.5% YoY) and the FY2025 annual result came in at $6.8 million, down 2.7% from the prior year.
- Cost of Revenue slipped to $1.9 million in Q1 2026, from $2.6 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $2.6 million in Q4 2025 to a low of $1.1 million in Q4 2022.
- A 5-year average of $1.6 million and a median of $1.7 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 271.55% — and 2025, when it sank 35.39%.
- Tracing HYPR's Cost of Revenue over 5 years: stood at $1.1 million in 2022, then jumped by 46.98% to $1.7 million in 2023, then retreated by 9.5% to $1.5 million in 2024, then soared by 73.85% to $2.6 million in 2025, then fell by 25.97% to $1.9 million in 2026.
- The last three Cost of Revenue figures came in at $1.9 million (Q1 2026), $2.6 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Hyperfine | 91.47 Mn | 46.71 Mn | 1.98 Mn | 1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Mn |
| Jun 30, 2026 | 1.92 Mn |
| Mar 31, 2026 | 1.92 Mn |
| Mar 31, 2026 | 1.92 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.94 Mn |